Expert Commentary

The FDA’s review of the data on open power morcellation was “inadequate, irresponsible” and a “disservice to women”

Author and Disclosure Information

Dr. William Parker discusses the FDA's estimate of the incidence of occult uterine malignancy at the time of benign hysterectomy and explains why he considers that estimate inaccurate and "a disservice to women.

He also describes the advantages of laparoscopic morcellation, compared with vaginal morcellation and morcellation through a mini-laparotomy, and summarizes what we know about how survival is affected if a uterine malignancy is inadvertently morcellated during surgery, and more.


Next Article:

Midurethral slings

Related Articles